Beijing Aomei Yixin Investment Consultant

Beijing Aomei Yixin Investment Consultant appears to be a PRC-registered company used within Aesthetic Medical International Holdings Group's medical aesthetics business in China. Public filings indicate it operates in the aesthetic healthcare/services segment rather than as a drug-development biotech or pharmaceutical company. The entity was acquired by Aesthetic Medical International in 2020 and is listed as a principal subsidiary in later SEC filings, suggesting it remained active within the group's structure afterward. Available public information does not show a therapeutic pipeline, drug candidates, or proprietary life sciences platform; instead, it appears tied to ownership, investment, and operation of aesthetic medical clinic assets in Beijing.